Download - Altered Pharmaco kinetics in Renal Disease
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
1/35
ALTERED PHARMACOKINETICS
IN RENAL DISEASE
BY- VJ
1
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
2/35
Contents Introduction
Renal clearance
Creatinine clearance
Renal impairment
Effect of renal impairment on pharmacokinetics Dose adjustment in renal disease
References
2
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
3/35
A Functional unit of Kidneys: Nephron Kidney has 1 to 1.5 million
functional nephron
Receives 25% of thecardiac output out-of-which10% is filtered (ultrafiltrateis devoid of Grossparticulate matter &globular proteins)
Physiological functions ofkidneys are
Maintains extra-
cellular fluid volume&osmolality Conserves importantsolutes Regulates acid-basebalance
Excretion ofexogenous substance 3
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
4/35
Three Major Process of Elimination in
Kidney
1.
Glomerular filtration
2. Active tubular secretion
3. Active (or)passive tubular reabsorption
4
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
5/35
Glomerular Filtration
Glomerular filtration occurs in the Bowmans Capsule.
1100 ml/min blood flow in the renal artery out-of-which 125 ml/min of
ultra-filtrate is formed; it is called the glomerular filtration rate (GFR).
Most of this ultrafiltrate is re-absorbed: final urine volume formed is at 1-2
ml/min.
Glomerular filtration depends on Molecular weight.
Inulin (a fructose polymer of MW- 5,200), Physiologically inert, non-toxic,
neither destroyed or synthesized nor stored within the kidney easily
measured in plasma & urine. Only filtered, no secretion or re-absorptionhence a measure of GFR.
Creatinine,inulin,mannitol,sodium thio sulphate are used to estimate GFR
5
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
6/35
Active tubular secretion
It is a carrier mediated process which requires energy for
transportation of compounds against the concentration
gradient. The system is capacity-limited and saturable.
Active tubular secretion occurs in the proximal tubule
region of the nephron.
Para amino hippuric acid and iodopyracet are used to
determine active secretion.
6
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
7/35
Tubular reabsorption
Tubular reabsorption is the process by which the solutes
and water removed from the tubular fluid andtransported in to blood.
Tubular reabsorption occurs in two processes.
1. Active process
2. passive process
Tubular reabsorption results in an increase in the half-
life of a drug.
Active tubular reabsorption is conducted by carriers and
pumps..
Passive tubular reabsorption is influenced by the pH of
the urine ,the pka of drug molecule.
7
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
8/35
Renal clearance
Renal clearance is the volume of blood or plasma which iscompletely cleared of the unchanged drug by the kidney per unittime.
CLR= Rate of urinary excretion
Plasma drug concentration
Renal clearance is the ratio of sum of glomerular filtration and secretion minusrate of reabsorption to plasma drug concentration(c).
CLR= Rate of filtration+ Rate of secretion Rate of reabsorptionplasma drug concentration
8
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
9/35
Estimation of creatinine clearance
The method recommended by the Food and drug Administration to
estimate renal function for the purposes of drug dosing is tomeasure creatinine clearance(crcl).
Creatinine is a by-product of muscle metabolism that is primarily
eliminated by glomerular filtration rate .Because of this property ,it
is used to measure glomerular filtration rate..
Creatinine clearance rates can be measured by collecting urine for
a specified period and collecting a blood sample for
determination of serum creatinine at the mid point of the
concurrent urine collection time
9
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
10/35
Clcr= Rate of urinary excretion of creatinine
Average serum creatinine concentration
Normal value: 100-125ml/min for 1.73m2 body surface area
Moderate renal failure: 20-50ml/min
Severe renal failure : less than 10ml/min
10
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
11/35
Eliminated only by the kidney
Freely filtered Good approximation
Neither secreted nor reabsorbed.
Easily and accurately measured
Why do we use creatinine for estimating glomerular filtration rate ?
11
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
12/35
Formula for estimating creatinine clearance
as per FDA
Crcl = Creatinine clearanceUcr = urine creatinine concentration(mg/dl)
Vurine= volume of urine collected in mlScr = serum creatinineT =time in min. of urine collection
Crcl(ml/min)=(Ucr . Vurine)/(Scr.T)
12
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
13/35
Comparison of creatinine clearance values
Creatinine clerance values condition
100-125 ml/min
20- 50 ml/min 10>ml/min
Normal
moderate renal failure severe renal failure
13
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
14/35
Limitations of serum creatinine measurement
(a) The relationship between the serum creatinine level and ClCr
(GFR) also depends on the endogenous production of creatinine by
muscle metabolism, which in turn depends largely on muscle bulk.
Eg. The elderly have less skeletal muscle than do younger persons, as
so an elderly person with the same serum creatinine level as a
young person can still have a low Clcr (GFR). Ie. an elderly person can
have renal impairment, despite a normal serum creatinine level.
14
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
15/35
Cockcroft and Gault method: According to this method creatinine clearance can be
calculated by fallowing formulas.
For males: Crclest={(140-age)BW}/(72.Scr)
For females: Crclest={0.85(140-age)BW}/(72.Scr)Crcl = ml/min
Body weight = kg
serum creatinine= mg/dl
Limitations: Should be used in adults aged 18years and older.
15
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
16/35
Renal impairment
The kidney is an important organ in regulating body fluids,
removal of metabolic waste, electrolyte balance and drug
excretion from the body
Impairment (or) degeneration of kidney function affects the
pharmacokinetics of the drugs.
some of the common causes for kidney failure include disease,
injury,and drug intoxication.
16
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
17/35
GFR
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
18/35
Common Causes of Kidney Failure
Hypertension
Chronic overloading of the kidney with f luid and electrolytes maylead to kidney insufficiency.
Diabetes mellitus
The disturbance of sugar metabolism and acid-base balance may lead
to or predispose a patient to degenerative renal disease.
Nephrotoxic drugs/metals
Certain drugs taken chronically may cause irreversible kidneydamageeg, the aminoglycosides, phenacetin, and heavy metals, suchas mercury and lead.
18
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
19/35
Hypovolemia
Any condition that causes a reduction in renal blood flow will eventually
lead to renal ischemia and damage.
Neophroallergens
Certain compounds may produce an immune type of sensitivity reaction
with nephritic syndromeeg, quartan malaria nephrotoxic serum.
Uremia generally reduces glomerular filtration and secretion, which lead to
decrease in renal drug excretion resulting in a longer elimination half-life the
administred drug.
19
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
20/35
Drug excretion Many studies shown that there is a linear relationship
between the renal clearance of a drug and creatinine
clearance in patients with varying degrees of renalfunction.
A=Drug specific constant
patients with renal disease also excrete lessunchanged drug in the urine than patients withnormal renal function.
Renal clearance=A* Creatinine clearance
20
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
21/35
Effect of renal disease on pharmacokinetics
Pharmacokinetic processes such as drug distribution(including volume
of distribution and renal excretion),and elimination ( biotransformation
and renal excretion) altered by renal impairment.
Therapeutic and toxic responses may altered as a result of changes in
drug sensitivity at the receptor site.
The effect of renal disease on pharmacokinetic processes such as
absorption, distribution, metbolism, elimination is as fallows. Acute diseases or trauma to the kidney can cause uremia, in which
glomerular filtration is impaired or reduced, leading to accumulation of
excessive fluid and blood nitrogenous products in the body.
21
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
22/35
Effect of renal disease on drug elimination
The effect of renal disease on the elimination of a drug
depends on the renal status of the patient and theelimination characteristics of the drug.
For many drugs CLE consists of renal(CLR) and nonrenal(CLNR) components.
CLE = CLR+ CLNR
Non renal excretion includes Biliary excretion,Pulmonary excretion, saliveryexcretion etc..
22
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
23/35
Mechanisms of renal excretion of drugs
23
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
24/35
Effect of renal disease on drug metabolism
Most drugs are not excreted by the kidneys unchanged but are
biotransformed to metabolites that are then excreted.
Renal failure retard the excretion of metabolites.
Renal failure alteres the metabolic clearance of the drug.
The impact of impaired renal function on drug metabolism is
dependent on the metabolic pathway.
24
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
25/35
25
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
26/35
Effect of renal disease on drug distribution
Impaired renal function is associated with important changes inthe binding of drugs to plasma proteins.
Protein binding in serum from uremic patients is decreased.
Most acidic drugs bind to the bilirubin site on albumin.
The reduced binding occurs when renal function is impaired forthe fallowing reasons.
a) Reduction in serum albumin concentration.
b) Structural changes in binding sites.
c) Displacement of drug from albumin binding sites by organic
molecules that accumulate in uremia.
26
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
27/35
For example phenytoin is an acidic drug showing changes in kinetics in
impaired renl function.
Due to the reduced protein binding volume of distribution is increased. 27
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
28/35
The volume of distribution of a drug can decrease if
compounds normally excreted by the kidney accumulate to the
extent that displacement of drug from tissue binding sites
occurs.
28
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
29/35
Effect of renal disease on drug absorption
Impaired renal function will result in increasedbioavailability of drugs exhibiting first-passmetabolism when the function of drug metabolizingenzymes is compromised.
29
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
30/35
Dose adjustment in renal disease
In the renal disease, the renal clearance and elimination rate arereduced, the elimination half-life is increased and the volume ofdistribution is altered.
The half- lives of some drugs are changed sufficiently in patients
with impaired renal function to warrant change in the usualdosage regimen to prevent accumulation of the drug in the bodyto toxic levels.
Generally, one should consider a possible, modest decrease in drugdoses when creatinine clearance is
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
31/35
Approaches for dose adjustment
Decrease the drug dose and retain the usual dosageinterval.
Retain the usual dose and increase the dosage
interval. Decrease the dosage and prolong the dosage interval.
The dosage change is usually proportional to therelative difference in half-life between the patients
with renal disease and the person with normal renalfunction.
31
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
32/35
Patients with renal failure sometimes need loading doses
because the time required to reach steady state with a particulardrug may be much longer than in patients with normal function.
This is particularly important when planning antibiotic or cardiac
glycoside therapy.
When dosing interval extension is applied in severe renal disease
to drugs with short half-lives , like the aminoglycoside antibiotics,
prolonged the periods of serum concentrations below the
therapeutic range may result.
32
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
33/35
33
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
34/35
References
Applied biopharmaceutics and pharmacokinetics Leon shargel.
Gibaldi Milo.Pharmacokinetic Variability-Disease.In:Biopharmaceutics
and ClinicalPharmacokinetics.
Applied clinical pharmacokinetics LARRY A.BAUER.
34
-
7/28/2019 Altered Pharmaco kinetics in Renal Disease
35/35
THANK YOU